AhmannASzeinbachSLGillJTraylorLGargSK. Comparing patient preferences and healthcare provider recommendations with the pen versus vial and syringe insulin delivery in patients with type 2 diabetes. Diabetes Technol Ther. 2014;16(2):76-83.
2.
AscheCVLuoWAagrenM. Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials. Curr Med Res Opin. 2013;29(10):1287-1296.
3.
BohannonNJOhannesianJPBurdanALHolcombeJHZagarA. Patient and physician satisfaction with the Humulin/Humalog pen, a new 3.0 ml prefilled pen devise for insulin delivery. Clin Ther. 2000;22:1049-1067.
4.
DaCostaSBrackenridgeBHicksD. A comparison of insulin pen use in the United States and the United Kingdom. Diabetes Educ. 2002;28:52-60.
5.
DavisEMBebeeACrawfordLDestacheC. Nursing satisfaction using insulin pens in hospitalized patients. Diabetes Educ. 2009;35(5):799-809.
6.
GraffMRMcClanahanMA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998;20:486-496.
7.
Institute for Safe Medication Practices. Hospitals should reconsider insulin pen use, says ISMP. http://www.ismp.org/pressroom/PR20130207.pdf. Published February7, 2013. Accessed August 10, 2015.
